Fig. 1.
Treatment survival curve for 76 systemic JIA patients: 54 tocilizumab and 22 anakinra
Survival was better on tocilizumab (89%; solid line) compared with anakinra (59%; dashed line) at one year (P = 0.002).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.